Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...
Streetwise Reports | October 15, 2019 |

Revolutionizing Egyptian oil exploration

TAG Oil’s Tech-Driven Breakthrough In the vast expanse of Egypt’s Western Desert, a hidden treasure of oil and gas resources lies in wait, largely untapped until now. The Badr oil field (BED-1) in the Western Desert holds the promisi...
Research | December 19, 2023 |

Energy MLP Makes 'Contrarian Play Outside the Renewables Arena'

A description of and comments about the play, an acquisition, are provided in a Raymond James report. In an Oct. 22 research note, Raymond James analyst Pavel Molchanov reported that Nextera Energy Partners LP (NEP:NYSE) agreed to acquire the Meade Pipeline for $1.3...
Streetwise Reports | October 30, 2019 |

Comparing Bitcoin to Other Sectors – Risk vs. Value

Quite a few traders have been discussing the recent rally of Bitcoin to recently breach the $10,000 level on May 7, 2020. This psychological price level is a major milestone for Bitcoin – even though the price has fallen into an extended Flag/Pennant formation since reaching...
Chris Vermeulen | June 1, 2020 |

Silver options strategies that could be lucrative for investors

In last Wednesday's Money Morning special report on silver , several of our financial gurus projected higher prices ahead for "the other precious metal." Since then, silver has climbed about 5% -- hitting $43 an ounce yesterday (Monday). Silver is now nearing its record ...
Larry D. Spears | October 28, 2012 |

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. Revive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS) , a company that focuses on repurposing drugs for infectious diseases and rare disorders, is prepari...
Streetwise Reports | June 4, 2020 |

The Credit Markets Gave Their Nod to the S&P 500 Upswing

Yesterday’s session did away with the non-confirmation of last week’s reversal from the 50% Fibonacci retracement. Junk corporate bonds lent their support to the stock upswing, and the S&P 500 closed above the 61.8% Fibonacci retracement. Will t...
Monica Kingsley | May 19, 2020 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

Global Negative Yields Tell A Story Of Shifting Economic Strength

Negative yields are becoming common for many of the world's most mature economies. The process of extending negative yields within these economies suggests that safety is more important than returns and that central banks realize that growth and increases in GDP are more impor...
Chris Vermeulen | August 21, 2019 |
1 2